Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study
5
Citation
36
Reference
10
Related Paper
Citation Trend
Keywords:
Association (psychology)
No AccessJournal of UrologyLetters to the Editor1 Dec 2022Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Letter.is a letter which has replyDiagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Reply. Philip Hanno Philip HannoPhilip Hanno Hayward, California More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002973AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Letter.." The Journal of Urology, 208(6), p. 1178 References 1. . Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022; 208(1):34-42. Link, Google Scholar 2. . Features of various bladder lesions and their impact on clinical symptoms and recurrence in interstitial cystitis. J Urol. 2021; 206(3):669-678. Link, Google Scholar 3. . Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology. 1990; 35(6):552-558. Google Scholar 4. . A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol. 1993; 150(3):845-848. Link, Google Scholar 5. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005; 65(4):654-658. Google Scholar 6. . Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo-controlled study. J Urol. 2015;193(3):857-862. Google Scholar Submitted August 29, 2022; accepted September 9, 2022; September 21, 2022. https://10.1097/JU.0000000000002973 © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology21 Sep 2022Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Reply. Volume 208Issue 6December 2022Page: 1178-1178 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Philip Hanno Hayward, California More articles by this author Expand All Submitted August 29, 2022; accepted September 9, 2022; September 21, 2022. https://10.1097/JU.0000000000002973 Advertisement PDF downloadLoading ...
Bladder Pain Syndrome
Cite
Citations (2)
The review of domestic and foreign literary sources for 2002–2014 made it possible to deepen into the problem of interstitial cystitis and put together different points of view and also to systematize the store of knowledge. Interstitial cystitis is a complex disease with marked clinical manifestation and defeat of urinary bladder with varying severity. For the purpose of diagnostics and treatment optimization of the disease in point in the review they presented the criteria whose existence will make it possible to make the diagnosis of interstitial cystitis. The multifactorial etiology of the disease requires the multiplane causal and pathogenetic therapy but more often empirical and symptomatic. In the article describe the algorithm of treatment of patients with the diagnosis of interstitial cystitis.
Etiology
Bladder Pain Syndrome
Cite
Citations (7)
Objective: To assess the treatment outcome of interstitial cystitis with sodium hyaluronate (cystistat) installation by O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI).Material and methods: From January 2019 to October 2020, 11 patients diagnosed with interstitial cystitis were treated with sodium hyaluronate (cystistat) installation. Each patient was assessed using the O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI) before and after therapy.Results: The number of interstitial cystitis patients who completed the installation program in this study was 11 patients. In the assessment of interstitial cystitis symptom index (ICSI), there was a significant clinical improvement in each of the symptoms, which are urgency, frequency, nocturia, and bladder pain, with statistical test results obtained p-value (0.002, 0.003, 0.003, and 0.003) consecutively. In the interstitial cystitis problem index (ICPI) study, clinical improvements were obtained from each symptom in the form of urgency, frequency, nocturia, and bladder pain with statistical test results obtained p-value (0.002, 0.003, 0.003, and 0.003) consecutively.Conclusion: In all interstitial cystitis patients who were treated with sodium hyaluronate installation in this study, there was a significant difference in the values of O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI) before and after therapy. This shows that sodium hyaluronate (cystistat) installation therapy is very effective for interstitial cystitis patients.
Sodium hyaluronate
Nocturia
Cite
Citations (0)
Interstitial cystitis or bladder pain syndrome is a frustrating symptom complex for both the patient and the clinician. Classic Hunner’s lesion interstitial cystitis is clearly a bladder disease and treating the bladder improves symptoms. Non-Hunner’s lesion interstitial cystitis or bladder pain syndrome likely has multiple aetiologies and in many cases the bladder is an innocent bystander in a bigger pelvic process. For many years, non-Hunner’s lesion interstitial cystitis has been treated with bladder-directed therapies, with poor overall outcomes. This literature review article will review the diagnosis and management of interstitial cystitis and encourage the reader to look beyond the bladder to achieve symptom relief.
Bladder Pain Syndrome
Cite
Citations (2)
Endometriosis and interstitial cystitis/painful bladder syndrome share similar symptoms. Interstitial cystitis was once considered rare, but it is now recognized as more common than previously thought. This review examines evidence that patients presenting with symptoms typically attributed to endometriosis or with unresolved pelvic pain after treatment for endometriosis may, in fact, have interstitial cystitis, and suggests approaches for appropriate diagnosis.
Bladder Pain Syndrome
Cite
Citations (24)
Read the full review for this Faculty Opinions recommended article: Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study.
Bladder Pain Syndrome
Clinical epidemiology
Cite
Citations (1)
Bladder Pain Syndrome
Cite
Citations (0)
Purpose: Interstitial cystitis is a chronic and debilitating syndrome but surprisingly little is known about its epidemiology. This study was designed to estimate the prevalence of interstitial cystitis among women in the United States. Materials and Methods: Female participants in the Nurses’ Health Study (NHS) I and I1 (184,583) were asked by mailed questionnaires whether they had ever been diagnosed with interstitial cystitis. We requested and reviewed medical records of women self-reporting interstitial cystitis. The accuracy of self-reports was evaluated using standardized criteria. Results: Among the 93,428 women who responded to the NHS I1 questionnaire and 91,155 women who responded to the NHS I questionnaire 1,354 (1.4%) and 357 (0.4%), respectively, self-reported interstitial cystitis. Based on medical record review 63 cases of interstitial cystitis were confirmed in NHS I1 and 47 in NHS I. The prevalence of interstitial cystitis was 67/100,000 women in NHS I1 and 52/100,000 in NHS I. There was no substantial variation in prevalence by age. Conclusions: The Prevalence of interstitial cystitis in the United States is more than 50% greater than previously reported and %fold greater than that reported in Europe. Interstitial cystitis is a chronic debilitating syndrome characterized by irritative voiding symptoms, suprapubic and/or pelvic pain and sterile, cytologically normal urine.’ Patients with interstitial cystitis may experience the need to void as frequently as every 30 minutes during the day and several times at night. Diagnosis of interstitial cystitis should be considered in the presence of symptoms, characteristic bladder findings on cystoscopy and the absence of another more clearly defined disease.’ Surprisingly little is known regarding the epidemiology. Interstitial cystitis occurs 6 to 11 times more commonly among women than men, and has been reported in pediatric, middle-aged and elderly patients. ’ None of the 3 previously published studies with estimates of prevalence was truly population based.2-4 Estimates have ranged from 18.6/100,000 women older than 20 years in Finland3 to approximately twice that in the United States.2 To estimate the prevalence of interstitial cystitis in the United States we performed a population based study among 184,583 participants in the Nurses’ Health Study (NHS) I and 11.
Cite
Citations (0)
No AccessJournal of UrologyEditorial1 Jan 2014How Far Have We Come in Interstitial Cystitis and How Far to Go? A Methodologist's Perspective Mireya Diaz Mireya DiazMireya Diaz More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.10.049AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "How Far Have We Come in Interstitial Cystitis and How Far to Go? A Methodologist's Perspective." The Journal of Urology, 191(1), pp. 11–12 References 1 : Consequences of interstitial cystitis/bladder pain symptoms on women's work participation and income: results from a national household sample. J Urol2014; 191: 83. Link, Google Scholar 2 : A randomized, double-blind, placebo controlled trial of adalimumab for treatment of interstitial cystitis/bladder pain syndrome. J Urol2014; 191: 77. Abstract, Google Scholar 3 : AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol2011; 185: 2162. Link, Google Scholar 4 : Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol2008; 53: 60. Google Scholar 5 : Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol2009; 182: 155. Link, Google Scholar 6 : Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol2010; 184: 1358. Link, Google Scholar 7 : The interstitial cystitis symptom index and problem index. Urology1997; 49: 58. Google Scholar 8 : Patient-reported outcomes in bladder pain syndrome: qui auget dolorem, auget et scientiam (as pain increases, so increases knowledge). Eur Urol2012; 61: 280. Google Scholar 9 : Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol2010; 183: 1853. Link, Google Scholar 10 : ‘Omics’ approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome. Int Neurourol J2012; 16: 159. Google Scholar 11 : Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Stat Med2012; 31: 1887. Google Scholar 12 : Multimodal therapy for interstitial cystitis. J Reprod Med2004; 49: 243. Google Scholar © 2014 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 191Issue 1January 2014Page: 11-12 Advertisement Copyright & Permissions© 2014 by American Urological Association Education and Research, Inc.MetricsAuthor Information Mireya Diaz More articles by this author Expand All Advertisement PDF DownloadLoading ...
Bladder Pain Syndrome
Cite
Citations (0)
Abstract The clinical guidelines for interstitial cystitis and related symptomatic conditions were revised by updating our previous guidelines. The current guidelines define interstitial cystitis/bladder pain syndrome as a condition with chronic pelvic pain, pressure or discomfort perceived to be related to the urinary bladder accompanied by other urinary symptoms, such as persistent urge to void or urinary frequency in the absence of confusable diseases. The characteristic symptom complex is collectively referred as hypersensitive bladder symptoms. Interstitial cystitis/bladder pain syndrome is divided into Hunner‐type interstitial cystitis and bladder pain syndrome; Hunner‐type interstitial cystitis and bladder pain syndrome represent interstitial cystitis/bladder pain syndrome with Hunner lesions and interstitial cystitis/bladder pain syndrome without Hunner lesions, respectively. So‐called non‐Hunner‐type interstitial cystitis featured by glomerulations or bladder bleeding after distension is included in bladder pain syndrome. The symptoms are virtually indistinguishable between Hunner‐type interstitial cystitis and bladder pain syndrome; however, Hunner‐type interstitial cystitis and bladder pain syndrome should be considered as a separate entity of disorder. Histopathology totally differs between Hunner‐type interstitial cystitis and bladder pain syndrome; Hunner‐type interstitial cystitis is associated with severe inflammation of the urinary bladder accompanied by lymphoplasmacytic infiltration and urothelial denudation, whereas bladder pain syndrome shows little pathological changes in the bladder. Pathophysiology would also differ between Hunner‐type interstitial cystitis and bladder pain syndrome, involving interaction of multiple factors, such as inflammation, autoimmunity, infection, exogenous substances, urothelial dysfunction, neural hyperactivity and extrabladder disorders. The patients should be treated differently based on the diagnosis of Hunner‐type interstitial cystitis or bladder pain syndrome, which requires cystoscopy to determine the presence or absence Hunner lesions. Clinical studies are to be designed to analyze outcomes separately for Hunner‐type interstitial cystitis and bladder pain syndrome.
Bladder Pain Syndrome
Cite
Citations (176)